Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.560NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.610NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.10 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.286NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.369NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.69NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.87NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.39.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.73 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.60 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.124.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XYNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.311NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.93NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.225NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.309NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.105NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.307NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used